NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Johnson & Johnson is set to acquire Intra-Cellular Therapies for $14.6 billion to enhance its neuroscience drug portfolio.

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...

Nonfarm payrolls in December increased more than expected, stoking fears of an inflation resurgence. Most investors think the Federal Reserve is done cutting interest rates for a while. Few ...

In this article, we are going to take a look at where Jefferies Financial Group Inc. (NYSE:JEF) stands against the other stocks Jim Cramer recently discussed. Jim Cramer, host of Mad Money ...

Jefferies Financial Group, Inc. is a holding company, which engages in the provision of financial services. It operates through the following segments: Investment Banking, Capital Markets, and ...

Zoetis CEO Kristen Peck talks about expanding their line of medications and she says the market for animal care products is ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...